Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1959 1
1960 1
1961 3
1963 1
1964 3
1965 25
1966 37
1967 46
1968 63
1969 61
1970 109
1971 104
1972 98
1973 88
1974 130
1975 120
1976 67
1977 103
1978 105
1979 128
1980 108
1981 106
1982 115
1983 114
1984 122
1985 120
1986 92
1987 95
1988 76
1989 88
1990 90
1991 81
1992 88
1993 86
1994 77
1995 82
1996 67
1997 85
1998 88
1999 94
2000 103
2001 76
2002 87
2003 93
2004 94
2005 120
2006 109
2007 122
2008 108
2009 107
2010 126
2011 141
2012 163
2013 169
2014 163
2015 182
2016 160
2017 133
2018 154
2019 143
2020 179
2021 151
2022 32
2023 3
2024 48

Text availability

Article attribute

Article type

Publication date

Search Results

5,828 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy of multiple myeloma.
Minnie SA, Hill GR. Minnie SA, et al. J Clin Invest. 2020 Apr 1;130(4):1565-1575. doi: 10.1172/JCI129205. J Clin Invest. 2020. PMID: 32149732 Free PMC article. Review.
Immunotherapy for multiple myeloma.
Kröger N, Mohty M, Nagler A, Yi Q. Kröger N, et al. Clin Dev Immunol. 2012;2012:797165. doi: 10.1155/2012/797165. Epub 2012 Dec 30. Clin Dev Immunol. 2012. PMID: 23346187 Free PMC article. No abstract available.
Editorial: Multiple Myeloma Immunotherapies.
Podar K. Podar K. Curr Cancer Drug Targets. 2017;17(9):768. doi: 10.2174/156800961709171005160041. Curr Cancer Drug Targets. 2017. PMID: 29117857 No abstract available.
Advances in immunotherapy in multiple myeloma.
Boussi L, Niesvizky R. Boussi L, et al. Curr Opin Oncol. 2017 Nov;29(6):460-466. doi: 10.1097/CCO.0000000000000407. Curr Opin Oncol. 2017. PMID: 28877078 Review.
Multiple myeloma.
Craver LF, Miller DG. Craver LF, et al. CA Cancer J Clin. 1966 Jul-Aug;16(4):142-55. doi: 10.3322/canjclin.16.4.142. CA Cancer J Clin. 1966. PMID: 4957754 Free article. No abstract available.
Facts and Hopes in Multiple Myeloma Immunotherapy.
Sperling AS, Anderson KC. Sperling AS, et al. Clin Cancer Res. 2021 Aug 15;27(16):4468-4477. doi: 10.1158/1078-0432.CCR-20-3600. Epub 2021 Mar 26. Clin Cancer Res. 2021. PMID: 33771856 Free PMC article. Review.
Immunotherapy of multiple myeloma.
Ruffini PA, Kwak LW. Ruffini PA, et al. Semin Hematol. 2001 Jul;38(3):260-7. doi: 10.1016/s0037-1963(01)90018-6. Semin Hematol. 2001. PMID: 11486314 Review.
5,828 results